Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.

The U.S. Food and Drug Administration (FDA) has issued its recommendations to vaccine makers on which virus strains to select when manufacturing influenza (flu) vaccines for the 2025-2026 U.S. flu ...

The global nicotine gums and mints market is projected to reach approximately USD 1,536.2 million by the end of 2024, with a ...

Annual ResultsBIOVERSYS ANNOUNCES REPORTING DATE FOR FULL-YEAR 2024 FINANCIAL RESULTS AND EVENT DETAILS 14.03.2025 / 07:00 CET/CESTBasel, Switzerland. March 14, 2025, 7am CETBioVersys AG (SIX: BIOV), ...

Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, ...

Pertussis Treatment Market Pertussis Medications and Vaccinations Leading Therapeutic Approaches Driving Stance of Companies in the Market: ...

Moderna stock is under pressure, again, as Robert F. Kennedy Jr. reportedly mulls pulling the company's federal funding to ...

Delmege Forsyth Energy Pvt Ltd, a subsidiary of Delmege Ltd, announces its appointment as the sole official ‘Macro ...

The Mall at Port City Colombo, in partnership with CAN Market, successfully hosted a vibrant three-day celebration in honor ...

Explore the Cancer Vaccines Market size, share, trends, and growth forecast. Learn about key industry players, advancements, and future opportunities in oncology ...

DelveInsight estimates approximately 52K cases of Graft Versus Host Disease in the 7MM. In 2023, the EU4 and the UK recorded ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.